Foundry 12-Month Momentum Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1MU | MICRON TECHNOLOGY INC | Technology | $958.80B | 14.88% |
2AMD | ADVANCED MICRO DEVICES INC | Technology | $808.39B | 12.55% |
3INTC | INTEL CORP | Technology | $477.67B | 7.42% |
4AMAT | APPLIED MATERIALS INC | Technology | $420.53B | 6.53% |
5CAT | CATERPILLAR INC | Industrials | $405.49B | 6.29% |
6LRCX | LAM RESEARCH CORP | Technology | $391.80B | 6.08% |
7KLAC | KLA CORP | Technology | $277.91B | 4.31% |
8DELL | DELL TECHNOLOGIES INC | Technology | $256.87B | 3.99% |
9SNDK | SANDISK CORP | Technology | $200.63B | 3.11% |
10STX | SEAGATE TECHNOLOGY HOLDINGS PLC | Technology | $176.62B | 2.74% |
11MRVL | MARVELL TECHNOLOGY INC | Technology | $165.06B | 2.56% |
12WDC | WESTERN DIGITAL CORP | Technology | $164.49B | 2.55% |
13GLW | CORNING INC | Technology | $133.06B | 2.07% |
14BE | BLOOM ENERGY CORP | Industrials | $61.14B | 0.95% |
15HPE | HEWLETT PACKARD ENTERPRISE CO | Technology | $60.67B | 0.94% |
16FIX | COMFORT SYSTEMS USA INC | Industrials | $58.93B | 0.91% |
17LITE | LUMENTUM HOLDINGS INC | Technology | $57.01B | 0.89% |
18COHR | COHERENT CORP | Technology | $54.31B | 0.84% |
19CIEN | CIENA CORP | Technology | $53.00B | 0.82% |
20ALAB | ASTERA LABS INC | Technology | $52.04B | 0.81% |
21TER | TERADYNE INC | Technology | $50.46B | 0.78% |
22RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 0.61% |
23RKLB | ROCKET LAB CORP | Industrials | $39.14B | 0.61% |
24CNC | CENTENE CORP | Healthcare | $32.81B | 0.51% |
25CRS | CARPENTER TECHNOLOGY CORP | Industrials | $27.71B | 0.43% |
26ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 0.41% |
27ATI | ATI INC | Industrials | $25.41B | 0.39% |
28ROIV | ROIVANT SCIENCES LTD | Healthcare | $24.82B | 0.39% |
29MRNA | MODERNA INC | Healthcare | $24.53B | 0.38% |
30MKSI | MKS INC | Technology | $21.93B | 0.34% |
31ENTG | ENTEGRIS INC | Technology | $21.16B | 0.33% |
32GH | GUARDANT HEALTH INC | Healthcare | $20.67B | 0.32% |
33STRL | STERLING INFRASTRUCTURE INC | Industrials | $19.59B | 0.30% |
34SNX | TD SYNNEX CORP | Technology | $19.40B | 0.30% |
35AMKR | AMKOR TECHNOLOGY INC | Technology | $15.60B | 0.24% |
36SITM | SITIME CORP | Technology | $14.65B | 0.23% |
37ALB | ALBEMARLE CORP | Basic Materials | $14.24B | 0.22% |
38ONTO | ONTO INNOVATION INC | Technology | $13.92B | 0.22% |
39TTMI | TTM TECHNOLOGIES INC | Technology | $13.71B | 0.21% |
40BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 0.21% |
41MOD | MODINE MANUFACTURING CO | Consumer Cyclical | $12.11B | 0.19% |
42COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $12.03B | 0.19% |
43AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.18% |
44VICR | VICOR CORP | Technology | $10.83B | 0.17% |
45ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 0.16% |
46KRYS | KRYSTAL BIOTECH INC | Healthcare | $10.46B | 0.16% |
47HUT | HUT 8 CORP | Financial Services | $10.30B | 0.16% |
48GSAT | GLOBALSTAR INC | Communication Services | $10.20B | 0.16% |
49APGE | APOGEE THERAPEUTICS INC | Healthcare | $10.10B | 0.16% |
50DAR | DARLING INGREDIENTS INC | Consumer Defensive | $10.03B | 0.16% |
51VSAT | VIASAT INC | Technology | $9.76B | 0.15% |
52HL | HECLA MINING CO | Basic Materials | $9.61B | 0.15% |
53MSGS | MADISON SQUARE GARDEN SPORTS CORP | Communication Services | $9.56B | 0.15% |
54KYMR | KYMERA THERAPEUTICS INC | Healthcare | $9.52B | 0.15% |
55ESI | ELEMENT SOLUTIONS INC | Basic Materials | $9.11B | 0.14% |
56WULF | TERAWULF INC | Financial Services | $9.00B | 0.14% |
57VIAV | VIAVI SOLUTIONS INC | Technology | $8.93B | 0.14% |
58OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.14% |
59PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | $8.77B | 0.14% |
60SYRE | SPYRE THERAPEUTICS INC | Healthcare | $8.70B | 0.14% |
61POWL | POWELL INDUSTRIES INC | Industrials | $8.48B | 0.13% |
62IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 0.13% |
63FORM | FORMFACTOR INC | Technology | $8.23B | 0.13% |
64AAOI | APPLIED OPTOELECTRONICS INC | Technology | $8.22B | 0.13% |
65IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 0.12% |
66PL | PLANET LABS PBC | Industrials | $8.01B | 0.12% |
67AGX | ARGAN INC | Industrials | $7.73B | 0.12% |
68PACS | PACS GROUP INC | Healthcare | $7.30B | 0.11% |
69ENS | ENERSYS | Industrials | $7.18B | 0.11% |
70LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.11% |
71COGT | COGENT BIOSCIENCES INC | Healthcare | $6.68B | 0.10% |
72VSXY | VICTORIA'S SECRET & CO | Consumer Cyclical | $6.47B | 0.10% |
73MXL | MAXLINEAR INC | Technology | $6.43B | 0.10% |
74CGON | CG ONCOLOGY INC | Healthcare | $6.34B | 0.10% |
75M | MACY'S INC | Consumer Cyclical | $6.23B | 0.10% |
76MYRG | MYR GROUP INC | Industrials | $6.10B | 0.09% |
77LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.08B | 0.09% |
78ERAS | ERASCA INC | Healthcare | $5.96B | 0.09% |
79GTX | GARRETT MOTION INC | Consumer Cyclical | $5.95B | 0.09% |
80OUT | OUTFRONT MEDIA INC | Real Estate | $5.85B | 0.09% |
81TWST | TWIST BIOSCIENCE CORP | Healthcare | $5.84B | 0.09% |
82KGS | KODIAK GAS SERVICES INC | Energy | $5.79B | 0.09% |
83ENVA | ENOVA INTERNATIONAL INC | Financial Services | $5.79B | 0.09% |
84DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | $5.77B | 0.09% |
85PRM | PERIMETER SOLUTIONS INC | Basic Materials | $5.61B | 0.09% |
86ORKA | ORUKA THERAPEUTICS INC | Healthcare | $5.59B | 0.09% |
87ACMR | ACM RESEARCH INC | Technology | $5.56B | 0.09% |
88TXG | 10X GENOMICS INC | Healthcare | $5.55B | 0.09% |
89SSRM | SSR MINING INC | Basic Materials | $5.31B | 0.08% |
90TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.08% |
91VSH | VISHAY INTERTECHNOLOGY INC | Technology | $5.15B | 0.08% |
92SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $5.10B | 0.08% |
93MTRN | MATERION CORP | Basic Materials | $5.10B | 0.08% |
94KLIC | KULICKE & SOFFA INDUSTRIES INC | Technology | $5.09B | 0.08% |
95DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.07% |
96VCYT | VERACYTE INC | Healthcare | $4.72B | 0.07% |
97LFST | LIFESTANCE HEALTH GROUP INC | Healthcare | $4.49B | 0.07% |
98LIVN | LIVANOVA PLC | Healthcare | $4.43B | 0.07% |
99SEI | SOLARIS ENERGY INFRASTRUCTURE INC | Energy | $4.43B | 0.07% |
100CELC | CELCUITY INC | Healthcare | $4.31B | 0.07% |
101INSW | INTERNATIONAL SEAWAYS INC | Energy | $4.29B | 0.07% |
102EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | $4.28B | 0.07% |
103ACLS | AXCELIS TECHNOLOGIES INC | Technology | $4.19B | 0.07% |
104COCO | VITA COCO COMPANY INC | Consumer Defensive | $4.18B | 0.06% |
105UCTT | ULTRA CLEAN HOLDINGS INC | Technology | $4.14B | 0.06% |
106TNGX | TANGO THERAPEUTICS INC | Healthcare | $4.13B | 0.06% |
107LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.06% |
108LASR | NLIGHT INC | Technology | $3.91B | 0.06% |
109DK | DELEK US HOLDINGS INC | Energy | $3.88B | 0.06% |
110RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.06% |
111CLMT | CALUMET INC | Energy | $3.73B | 0.06% |
112ALMS | ALUMIS INC | Healthcare | $3.65B | 0.06% |
113NHC | NATIONAL HEALTHCARE CORP | Healthcare | $3.56B | 0.06% |
114MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.06% |
115CALY | CALLAWAY GOLF CO | Consumer Cyclical | $3.48B | 0.05% |
116GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | $3.45B | 0.05% |
117RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.05% |
118ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | $3.24B | 0.05% |
119ONDS | ONDAS INC | Technology | $3.23B | 0.05% |
120VECO | VEECO INSTRUMENTS INC | Technology | $3.19B | 0.05% |
121KN | KNOWLES CORP | Technology | $3.01B | 0.05% |
122AXTI | AXT INC | Technology | $3.00B | 0.05% |
123MBX | MBX BIOSCIENCES INC | Healthcare | $2.99B | 0.05% |
124ICHR | ICHOR HOLDINGS LTD | Technology | $2.88B | 0.04% |
125ADEA | ADEIA INC | Technology | $2.80B | 0.04% |
126VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.04% |
127ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.72B | 0.04% |
128TRVI | TREVI THERAPEUTICS INC | Healthcare | $2.71B | 0.04% |
129ANDE | ANDERSONS INC | Consumer Defensive | $2.70B | 0.04% |
130HLIO | HELIOS TECHNOLOGIES INC | Industrials | $2.68B | 0.04% |
131UNIT | UNITI GROUP INC | Real Estate | $2.68B | 0.04% |
132KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.04% |
133FLNC | FLUENCE ENERGY INC | Utilities | $2.59B | 0.04% |
134KALU | KAISER ALUMINUM CORP | Basic Materials | $2.58B | 0.04% |
135GRDN | GUARDIAN PHARMACY SERVICES INC | Healthcare | $2.57B | 0.04% |
136AEHR | AEHR TEST SYSTEMS | Technology | $2.55B | 0.04% |
137DCO | DUCOMMUN INC | Industrials | $2.54B | 0.04% |
138QURE | UNIQURE NV | Healthcare | $2.54B | 0.04% |
139SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.04% |
140COHU | COHU INC | Technology | $2.41B | 0.04% |
141ATRO | ASTRONICS CORP | Industrials | $2.41B | 0.04% |
142ROG | ROGERS CORP | Technology | $2.36B | 0.04% |
143OUST | OUSTER INC | Technology | $2.36B | 0.04% |
144NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.31B | 0.04% |
145SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.03% |
146DHC | DIVERSIFIED HEALTHCARE TRUST | Real Estate | $2.22B | 0.03% |
147VSTS | VESTIS CORP | Industrials | $2.18B | 0.03% |
148AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.03% |
149PEB | PEBBLEBROOK HOTEL TRUST | Real Estate | $2.16B | 0.03% |
150AXGN | AXOGEN INC | Healthcare | $2.12B | 0.03% |
151GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | $2.07B | 0.03% |
152CDNA | CAREDX INC | Healthcare | $2.05B | 0.03% |
153RAPP | RAPPORT THERAPEUTICS INC | Healthcare | $2.04B | 0.03% |
154NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.03% |
155PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.03% |
156EZPW | EZCORP INC | Financial Services | $1.97B | 0.03% |
157ECPG | ENCORE CAPITAL GROUP INC | Financial Services | $1.96B | 0.03% |
158ATEX | ANTERIX INC | Communication Services | $1.96B | 0.03% |
159DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.03% |
160TYRA | TYRA BIOSCIENCES INC | Healthcare | $1.91B | 0.03% |
161NGL | NGL ENERGY PARTNERS LP | Energy | $1.89B | 0.03% |
162MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $1.87B | 0.03% |
163ALGT | ALLEGIANT TRAVEL CO | Industrials | $1.86B | 0.03% |
164BCAX | BICARA THERAPEUTICS INC | Healthcare | $1.82B | 0.03% |
165LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Industrials | $1.81B | 0.03% |
166STOK | STOKE THERAPEUTICS INC | Healthcare | $1.81B | 0.03% |
167HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.74B | 0.03% |
168BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.03% |
169TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.03% |
170CBL | CBL & ASSOCIATES PROPERTIES INC | Real Estate | $1.71B | 0.03% |
171ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.03% |
172FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.03% |
173CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.03% |
174TH | TARGET HOSPITALITY CORP | Industrials | $1.64B | 0.03% |
175TE | T1 ENERGY INC | Industrials | $1.63B | 0.03% |
176PSNL | PERSONALIS INC | Healthcare | $1.61B | 0.03% |
177PLPC | PREFORMED LINE PRODUCTS CO | Industrials | $1.60B | 0.02% |
178PUMP | PROPETRO HOLDING CORP | Energy | $1.59B | 0.02% |
179INNV | INNOVAGE HOLDING CORP | Healthcare | $1.56B | 0.02% |
180SKYT | SKYWATER TECHNOLOGY INC | Technology | $1.54B | 0.02% |
181ATLC | ATLANTICUS HOLDINGS CORP | Financial Services | $1.52B | 0.02% |
182SEPN | SEPTERNA INC | Healthcare | $1.51B | 0.02% |
183ALNT | ALLIENT INC | Technology | $1.49B | 0.02% |
184AIP | ARTERIS INC | Technology | $1.43B | 0.02% |
185RMIX | SUNCRETE INC | Basic Materials | $1.40B | 0.02% |
186VPG | VISHAY PRECISION GROUP INC | Technology | $1.38B | 0.02% |
187LINC | LINCOLN EDUCATIONAL SERVICES CORP | Consumer Defensive | $1.36B | 0.02% |
188REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.02% |
189BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.02% |
190FBYD | FALCON'S BEYOND GLOBAL INC | Industrials | $1.35B | 0.02% |
191NWPX | NWPX INFRASTRUCTURE INC | Industrials | $1.33B | 0.02% |
192PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.32B | 0.02% |
193UFCS | UNITED FIRE GROUP INC | Financial Services | $1.31B | 0.02% |
194INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.02% |
195TTI | TETRA TECHNOLOGIES INC | Energy | $1.25B | 0.02% |
196CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | $1.25B | 0.02% |
197FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.02% |
198TDAY | USA TODAY CO INC | Consumer Cyclical | $1.25B | 0.02% |
199NBR | NABORS INDUSTRIES LTD | Energy | $1.24B | 0.02% |
200DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.19B | 0.02% |
201AVNS | AVANOS MEDICAL INC | Healthcare | $1.17B | 0.02% |
202MYE | MYERS INDUSTRIES INC | Consumer Cyclical | $1.17B | 0.02% |
203ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.16B | 0.02% |
204SVRA | SAVARA INC | Healthcare | $1.13B | 0.02% |
205CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | $1.13B | 0.02% |
206RHLD | RESOLUTE HOLDINGS MANAGEMENT INC | Industrials | $1.10B | 0.02% |
207GOLD | GOLDCOM INC | Financial Services | $1.09B | 0.02% |
208CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $1.09B | 0.02% |
209JBIO | JADE BIOSCIENCES INC | Healthcare | $1.03B | 0.02% |
210AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.02% |
211BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.02% |
212APPS | DIGITAL TURBINE INC | Technology | $1.01B | 0.02% |
213OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | $1.00B | 0.02% |
214ABX | ABACUS GLOBAL MANAGEMENT INC | Financial Services | $994M | 0.02% |
215EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $984M | 0.02% |
216ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.02% |
217LWLG | LIGHTWAVE LOGIC INC | Basic Materials | $960M | 0.01% |
218ANNX | ANNEXON INC | Healthcare | $950M | 0.01% |
219TROX | TRONOX HOLDINGS PLC | Basic Materials | $932M | 0.01% |
220APEI | AMERICAN PUBLIC EDUCATION INC | Consumer Defensive | $930M | 0.01% |
221ARKO | ARKO CORP | Consumer Cyclical | $893M | 0.01% |
222MOV | MOVADO GROUP INC | Consumer Cyclical | $859M | 0.01% |
223AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.01% |
224ACRS | ACLARIS THERAPEUTICS INC | Healthcare | $793M | 0.01% |
225DSGN | DESIGN THERAPEUTICS INC | Healthcare | $785M | 0.01% |
226CLYM | CLIMB BIO INC | Healthcare | $727M | 0.01% |
227OMER | OMEROS CORP | Healthcare | $701M | 0.01% |
228MAMA | MAMA'S CREATIONS INC | Consumer Defensive | $700M | 0.01% |
229PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.01% |
230PSTL | POSTAL REALTY TRUST INC | Real Estate | $664M | 0.01% |
231LPTH | LIGHTPATH TECHNOLOGIES INC | Technology | $657M | 0.01% |
232FEIM | FREQUENCY ELECTRONICS INC | Technology | $650M | 0.01% |
233TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.01% |
234ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.01% |
235CLDT | CHATHAM LODGING TRUST | Real Estate | $624M | 0.01% |
236FET | FORUM ENERGY TECHNOLOGIES INC | Energy | $593M | 0.01% |
237PACK | RANPAK HOLDINGS CORP | Consumer Cyclical | $583M | 0.01% |
238STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.01% |
239FDMT | 4D MOLECULAR THERAPEUTICS INC | Healthcare | $575M | 0.01% |
240IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.01% |
241RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.01% |
242RLMD | RELMADA THERAPEUTICS INC | Healthcare | $550M | 0.01% |
243NPCE | NEUROPACE INC | Healthcare | $548M | 0.01% |
244ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.01% |
245PKOH | PARK OHIO HOLDINGS CORP | Industrials | $544M | 0.01% |
246XMAX | XMAX INC | Consumer Cyclical | $541M | 0.01% |
247CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | $532M | 0.01% |
248ORN | ORION GROUP HOLDINGS INC | Industrials | $518M | 0.01% |
249ZURA | ZURA BIO LTD | Healthcare | $518M | 0.01% |
250NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.01% |
251KYTX | KYVERNA THERAPEUTICS INC | Healthcare | $453M | 0.01% |
252ALTO | ALTO INGREDIENTS INC | Basic Materials | $453M | 0.01% |
253STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.01% |
254BETR | BETTER HOME & FINANCE HOLDING CO | Financial Services | $442M | 0.01% |
255FSTR | FOSTER L B CO | Industrials | $439M | 0.01% |
256PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.01% |
257FLXS | FLEXSTEEL INDUSTRIES INC | Consumer Cyclical | $391M | 0.01% |
258STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.01% |
259ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.01% |
260ELMD | ELECTROMED INC | Healthcare | $349M | 0.01% |
261MRAM | EVERSPIN TECHNOLOGIES INC | Technology | $341M | 0.01% |
262CV | CAPSOVISION INC | Healthcare | $335M | 0.01% |
263TWIN | TWIN DISC INC | Industrials | $326M | 0.01% |
264VELO | VELO3D INC | Technology | $316M | 0.00% |
265OSS | ONE STOP SYSTEMS INC | Technology | $313M | 0.00% |
266OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.00% |
267DBI | DESIGNER BRANDS INC | Consumer Cyclical | $290M | 0.00% |
268QTTB | Q32 BIO INC | Healthcare | $255M | 0.00% |
269SRZN | SURROZEN INC | Healthcare | $255M | 0.00% |
270RELL | RICHARDSON ELECTRONICS LTD | Technology | $250M | 0.00% |
271ASYS | AMTECH SYSTEMS INC | Technology | $242M | 0.00% |
272ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.00% |
273KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.00% |
274BDSX | BIODESIX INC | Healthcare | $204M | 0.00% |
275FOCL | FOCAL INC | Healthcare | $204M | 0.00% |
276INTT | INTEST CORP | Technology | $169M | 0.00% |
277KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.00% |
278AP | AMPCO PITTSBURGH CORP | Industrials | $156M | 0.00% |
279SIF | SIFCO INDUSTRIES INC | Industrials | $141M | 0.00% |
280OCC | OPTICAL CABLE CORP | Technology | $130M | 0.00% |
281VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.00% |
282VATE | INNOVATE CORP | Industrials | $123M | 0.00% |
283SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.00% |
284WYY | WIDEPOINT CORP | Technology | $115M | 0.00% |
285TRT | TRIO-TECH INTERNATIONAL | Technology | $103M | 0.00% |
286CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.00% |
287RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
288INTG | INTERGROUP CORP | Consumer Cyclical | $84M | 0.00% |
289NRXS | NEURAXIS INC | Healthcare | $84M | 0.00% |
290VNCE | VINCE HOLDING CORP | Consumer Cyclical | $83M | 0.00% |
291ROLR | HIGH ROLLER TECHNOLOGIES INC | Consumer Cyclical | $76M | 0.00% |
292BNAI | BRAND ENGAGEMENT NETWORK INC | Technology | $76M | 0.00% |
293BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.00% |
294LONA | LEONABIO INC | Healthcare | $68M | 0.00% |
295NDLS | NOODLES & CO | Consumer Cyclical | $66M | 0.00% |
296EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $6.44T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 97% toward Large, 83% toward Growth. +2% unclassified (37 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual48.7%Margin-23.7%
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 45.2% | 2.2% |
| 3 yearsp.a. | 41.4% | 18.4% |
| 5 yearsp.a. | 23.9% | 16.9% |
| 10 yearsp.a. | 23.1% | 11.5% |
| Since inceptionp.a. | 13.6% | 5.7% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 38.2% | 12.0% |
| 2025 | 11.0% | -11.3% |
| 2024 | 70.7% | 57.4% |
| 2023 | 36.8% | 16.2% |
| 2022 | -16.6% | 22.3% |
| 2021 | -0.4% | -21.2% |
| 2020 | 59.1% | 50.1% |
| 2019 | 22.8% | -13.1% |
| 2018 | 1.8% | 24.8% |
| 2017 | 31.8% | 17.6% |
| 2016 | 4.4% | -22.0% |
| 2015 | 2.3% | 23.8% |
| 2014 | 12.9% | 10.2% |
| 2013 | 33.8% | -9.6% |
| 2012 | 13.5% | -6.2% |
| 2011 | -6.7% | 7.9% |
| 2010 | 26.6% | 1.2% |
| 2009 | 13.7% | -44.3% |
| 2008 | -32.5% | 41.5% |
| 2007 | 29.6% | 33.7% |
| 2006 | 2.7% | -15.1% |
| 2005 | 14.0% | 4.7% |
| 2004 | 1.9% | -9.3% |
| 2003 | 55.3% | 12.9% |
| 2002 | -16.3% | 22.8% |
| 2001 | -17.1% | -18.6% |
| 2000 | -27.0% | -24.8% |
| 1999 | 113.3% | 93.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry 12-Month Momentum Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a 12-Month Momentum signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.